| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/16/2009 | WO2009087673A1 Improved process for the manufacture of anagrelide hidrochloride monhydrate |
| 07/16/2009 | WO2009087238A2 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | WO2009061851A3 Modulation of factor 7 expression |
| 07/16/2009 | US20090182125 Stability, reduced toxicity; covalently linked imidazole functionality |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182030 Process for the preparation of amorphous calcium salt of atorvastatin |
| 07/16/2009 | US20090182013 Derivatives of 5-Thioxylopyranose and Use of Same for Treatment |
| 07/16/2009 | US20090181987 Inhibitors of brutons tyrosine kinase |
| 07/16/2009 | US20090181983 Six-membered heterocycles useful as serine protease inhibitors |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181895 Stabilised Compositions of Factor VII Polypeptides |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181057 Methods and Compositions for the Inhibition of Thrombus Formation |
| 07/16/2009 | US20090180995 Novel anticoagulant polypeptides and complex |
| 07/16/2009 | DE10301300B4 Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein Use of acylated 4-amidino and 4-Guanidinobenzylaminen for the inhibition of plasma kallikrein |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711160A1 Pterin analog for treating bh4 responsive condition |
| 07/15/2009 | EP2078532A1 Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device |
| 07/15/2009 | EP2078074A2 Dosing regimen of activated protein c and variants having reduced anticoagulant activity |
| 07/15/2009 | EP2078025A2 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof |
| 07/15/2009 | EP2077999A1 Hydroxamates as inhibitors of histone deacetylase |
| 07/15/2009 | EP2077995A1 Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
| 07/15/2009 | EP2077992A2 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/15/2009 | EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | CN100513392C Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 07/15/2009 | CN100512842C Disinfectant |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/14/2009 | CA2521133C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha.-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/14/2009 | CA2338090C Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies |
| 07/09/2009 | WO2009086426A2 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
| 07/09/2009 | WO2009084732A1 Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy |
| 07/09/2009 | WO2009084531A1 Monosebacate of pyrazole derivative |
| 07/09/2009 | WO2008040002A3 Methods, compositions and articles of manufacture for hif modulating compounds |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176825 Prolyl hydroxylase inhibitors |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176803 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
| 07/09/2009 | US20090176758 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | US20090176708 Chemically modified factor ix |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175828 Coagulation Factor X Polypeptides With Modified Activation Properties |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/08/2009 | EP2077262A1 Iminopyridine derivative and use thereof |
| 07/08/2009 | EP2076519A2 Novel dithiolopyrrolones and their therapeutical applications |
| 07/08/2009 | EP2076511A1 Novel heteroaryl carboxamides |
| 07/08/2009 | EP2076243A1 Liquid formulation of g-csf |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1265929B1 Anti-c2/c2a inhibitors of complement activation |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/08/2009 | CN100508962C The use of kauranes compounds in the preparation of medicament |
| 07/08/2009 | CA2645701A1 Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same |
| 07/07/2009 | US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis |
| 07/07/2009 | US7557188 von Willebrand factor; von Willebrand's disease, phenotypic hemophilia, hemophilia A and factor VIII inhibitors |
| 07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557102 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/02/2009 | WO2009082449A2 Resuscitation fluid |
| 07/02/2009 | WO2009082340A1 Method for monitoring the progression of fibrinolysis'646 |
| 07/02/2009 | WO2009080694A1 Thiazole derivatives used as pi 3 kinase inhibitors |
| 07/02/2009 | WO2009080248A1 Substituted 2-phenylpyrimidine-5-carboxylic acids and the use thereof |
| 07/02/2009 | WO2009080227A2 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 07/02/2009 | WO2009080226A2 Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| 07/02/2009 | WO2009079922A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079910A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
| 07/02/2009 | WO2009079876A1 3-acylated shikimic acid or methyl (ethyl) shikimate |
| 07/02/2009 | WO2009079690A1 Haemostasis- modulating compositions and uses therefor |
| 07/02/2009 | WO2009027844A3 Crf conjugates with extended half-lives |
| 07/02/2009 | WO2007127377A3 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease |
| 07/02/2009 | US20090170942 Ester derivative and use thereof |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170756 Chimeric natriuretic peptides |
| 07/02/2009 | US20090170748 Plasmid mediated supplementation for treating chronically ill subjects |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169660 A composition of radix codonopsis and radix astragali, a method for preparation thereof and its application |
| 07/02/2009 | CA2710338A1 Resuscitation fluid |
| 07/02/2009 | CA2710122A1 Thiazole derivatives used as pi 3 kinase inhibitors |
| 07/02/2009 | CA2709530A1 Monosebacate of pyrazole derivative |
| 07/02/2009 | CA2709337A1 Haemostasis- modulating compositions and uses therefor |
| 07/02/2009 | CA2708819A1 An erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof |